The technique highlights differences in how water molecules move through cancerous tissue in comparison to healthy tissue.

Experts hope the information gained from their research could help providers better determine whether patients will regain mobility after sustaining an injury. 

James Min, MD, Cleerly's founder and CEO, changed careers to address what he saw as a major unmet need in cardiology.

“These findings raise the question of whether insurance reimbursement impacts referral patterns for other conditions and specialties, and the extent to which it may outweigh evidence-based care decisions."

New findings are calling into question the notion that white matter hyperintensities are biomarkers of brain injuries. 

Although the vast majority of nodules are benign, many are referred for biopsy as a precaution to rule out malignancy.

New data suggest the model outperforms publicly available segmentation algorithms.  

The product was developed to both improve image quality and shorten image acquisition times.